See more : FTAC Parnassus Acquisition Corp. (FTPAW) Income Statement Analysis – Financial Results
Complete financial analysis of Assicurazioni Generali S.p.A. (ARZGF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Assicurazioni Generali S.p.A., a leading company in the Insurance – Diversified industry within the Financial Services sector.
You may be interested
- Deoleo, S.A. (0M0Q.L) Income Statement Analysis – Financial Results
- Cadiz Inc. (0HS4.L) Income Statement Analysis – Financial Results
- XL Fleet Corp. (XL) Income Statement Analysis – Financial Results
- ION Acquisition Corp 1 Ltd. (IACA) Income Statement Analysis – Financial Results
- NTT Data Intramart Corporation (3850.T) Income Statement Analysis – Financial Results
Assicurazioni Generali S.p.A. (ARZGF)
About Assicurazioni Generali S.p.A.
Assicurazioni Generali S.p.A. provides various insurance solutions. The company operates through four segments: Non-Life; Life; Asset Management; and Holding and Other Business. It offers saving and protection insurance products for individuals and family; unit linked products with investment purposes; and motor, motor third-party liability, casualty, accident, health, and commercial and industrial risks insurance products. The company also provides equity and fixed-income funds, and alternative products; and investment advisory, asset management, and financial planning services. It operates in Italy, France, Germany, Austria, Czech Republic, Poland, Hungary, Slovakia, Serbia, Montenegro, Romania, Slovenia, Bulgaria, Croatia, Russia, Spain, Switzerland, the Americas, Southern Europe, and Asia. The company was formerly known as Assicurazioni Generali Austro-Italiche and changed its name to Assicurazioni Generali S.p.A. in 1848. Assicurazioni Generali S.p.A. was founded in 1831 and is headquartered in Trieste, Italy.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57.20B | 72.64B | 92.79B | 77.72B | 88.40B | 67.93B | 82.11B | 79.83B | 85.73B | 82.30B | 79.39B | 78.56B | 73.32B | 90.78B | 90.66B | 70.55B | 83.27B | 81.26B | 81.72B | 71.09B | 21.58B |
| Cost of Revenue | 8.72B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 48.48B | 72.64B | 92.79B | 77.72B | 88.40B | 67.93B | 82.11B | 79.83B | 85.73B | 82.30B | 79.39B | 78.56B | 73.32B | 90.78B | 90.66B | 70.55B | 83.27B | 81.26B | 81.72B | 71.09B | 21.58B |
| Gross Profit Ratio | 84.75% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 966.00M | 3.35B | 2.81B | 2.74B | 2.74B | 2.44B | 2.58B | 2.59B | 2.58B | 2.50B | 2.99B | 3.18B | 3.46B | 3.47B | 3.34B | 3.51B | 3.11B | 2.92B | 9.44B | 9.58B | 2.03B |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 966.00M | 3.35B | 2.81B | 2.74B | 2.74B | 2.44B | 2.58B | 2.59B | 2.58B | 2.50B | 2.99B | 3.18B | 3.46B | 3.47B | 3.34B | 3.51B | 3.11B | 2.92B | 9.44B | 9.58B | 2.03B |
| Other Expenses | 0.00 | -71.52B | -91.44B | -77.38B | -87.40B | -65.92B | -80.37B | -1.82B | -1.94B | -3.51B | -4.76B | -6.16B | -74.97B | -4.89B | -7.58B | 11.51B | -18.81B | -4.24B | -19.25B | -15.81B | 1.79B |
| Operating Expenses | 50.84B | -68.18B | -88.63B | -74.64B | -84.67B | -63.49B | -77.80B | 771.00M | 641.00M | -1.01B | -1.78B | -2.99B | -71.52B | -1.42B | -4.24B | 15.02B | -15.70B | -1.31B | -9.81B | -6.23B | 3.82B |
| Cost & Expenses | 50.84B | 67.90B | 88.21B | 74.33B | 84.81B | 64.48B | 78.42B | 76.67B | 82.33B | 79.35B | 77.07B | 76.92B | 71.52B | 87.94B | 88.49B | 69.02B | 78.55B | 77.34B | 78.17B | 67.99B | 19.58B |
| Interest Income | 0.00 | 7.75B | 7.37B | 7.47B | 7.84B | 7.29B | 8.62B | 8.96B | 9.09B | 8.71B | 8.79B | 8.92B | 0.00 | 10.21B | 9.68B | 10.72B | 1.79B | 9.15B | 1.48B | 0.00 | 0.00 |
| Interest Expense | 793.00M | 715.00M | 736.00M | 837.00M | 1.02B | 1.01B | 1.03B | 1.11B | 1.10B | 1.30B | 1.38B | 1.37B | 1.30B | 1.24B | 1.26B | 1.53B | 3.10B | 1.05B | 2.25B | 2.32B | 0.00 |
| Depreciation & Amortization | -6.38B | 464.00M | 544.00M | 616.00M | 573.00M | 379.00M | 400.00M | 435.00M | 412.00M | 417.00M | 650.00M | 1.07B | 0.00 | 1.29B | 1.36B | 1.53B | 3.10B | 1.05B | 2.25B | 1.87B | 0.00 |
| EBITDA | -1.19B | 4.82B | 5.59B | 4.77B | 5.08B | 4.68B | 4.80B | 4.55B | 4.98B | 4.72B | 4.65B | 3.79B | 4.10B | 4.67B | 3.89B | 3.54B | 6.31B | 5.21B | 4.32B | 3.64B | 1.73B |
| EBITDA Ratio | -2.07% | 7.62% | 5.32% | 5.04% | 5.09% | 7.36% | 5.75% | 5.70% | 5.43% | 5.37% | 5.90% | 3.44% | 2.46% | 4.54% | 3.89% | 4.35% | 9.39% | 6.12% | 7.09% | 6.99% | 8.03% |
| Operating Income | 6.38B | 4.46B | 4.16B | 3.08B | 3.73B | 4.45B | 4.31B | 3.16B | 3.41B | 2.95B | 2.32B | 1.64B | 1.80B | 2.84B | 2.17B | 1.54B | 4.72B | 3.92B | 3.55B | 3.10B | 1.73B |
| Operating Income Ratio | 11.16% | 6.14% | 4.48% | 3.97% | 4.22% | 6.54% | 5.25% | 3.96% | 3.97% | 3.59% | 2.93% | 2.08% | 2.46% | 3.12% | 2.39% | 2.18% | 5.66% | 4.82% | 4.34% | 4.35% | 8.03% |
| Total Other Income/Expenses | -810.00M | 27.00M | -876.00M | -1.33B | -1.27B | -1.27B | -2.22B | -810.00M | -154.00M | -376.00M | -1.69B | -1.99B | 1.81B | -2.01B | -1.56B | -1.05B | -871.80M | -935.50M | -794.50M | -808.80M | -15.76B |
| Income Before Tax | 5.57B | 4.74B | 4.58B | 3.39B | 3.59B | 3.45B | 3.69B | 3.16B | 3.41B | 2.95B | 2.32B | 1.64B | 1.80B | 2.84B | 2.17B | 1.54B | 4.72B | 3.92B | 3.55B | 3.10B | 1.99B |
| Income Before Tax Ratio | 9.74% | 6.52% | 4.94% | 4.36% | 4.06% | 5.08% | 4.49% | 3.95% | 3.97% | 3.59% | 2.93% | 2.09% | 2.46% | 3.12% | 2.39% | 2.18% | 5.66% | 4.82% | 4.34% | 4.35% | 9.24% |
| Income Tax Expense | 1.54B | 1.55B | 1.38B | 1.18B | 1.12B | 1.13B | 1.17B | 918.00M | 1.11B | 1.03B | 742.00M | 1.24B | 651.80M | 869.30M | 498.10M | 472.50M | 1.34B | 1.06B | 1.14B | 984.50M | 718.08M |
| Net Income | 3.66B | 2.91B | 2.85B | 1.74B | 2.67B | 2.31B | 2.11B | 2.08B | 2.03B | 1.67B | 1.92B | 90.00M | 1.15B | 2.02B | 1.77B | 1.06B | 3.37B | 2.86B | 2.41B | 1.67B | 1.02B |
| Net Income Ratio | 6.40% | 4.01% | 3.07% | 2.24% | 3.02% | 3.40% | 2.57% | 2.61% | 2.37% | 2.03% | 2.41% | 0.11% | 1.57% | 2.22% | 1.95% | 1.51% | 4.05% | 3.52% | 2.95% | 2.34% | 4.70% |
| EPS | 2.43 | 1.85 | 1.81 | 1.11 | 1.70 | 1.48 | 1.35 | 1.34 | 1.30 | 1.07 | 1.24 | 0.06 | 0.56 | 1.10 | 0.93 | 0.64 | 2.11 | 1.72 | 1.37 | 1.19 | 0.72 |
| EPS Diluted | 2.42 | 1.84 | 1.78 | 1.09 | 1.68 | 1.45 | 1.33 | 1.32 | 1.29 | 1.06 | 1.24 | 0.06 | 0.56 | 1.10 | 0.93 | 0.64 | 2.11 | 1.72 | 1.37 | 1.19 | 0.72 |
| Weighted Avg Shares Out | 1.54B | 1.57B | 1.57B | 1.57B | 1.57B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.54B | 1.54B | 1.55B | 1.41B | 1.35B | 1.38B | 1.40B | 1.40B | 1.39B | 1.40B |
| Weighted Avg Shares Out (Dil) | 1.55B | 1.59B | 1.60B | 1.59B | 1.59B | 1.59B | 1.58B | 1.58B | 1.57B | 1.57B | 1.55B | 1.54B | 1.54B | 1.55B | 1.41B | 1.35B | 1.38B | 1.40B | 1.40B | 1.39B | 1.40B |
Assicurazioni Generali: M&A Upside And Solid Execution
€500 million buyback in 2024 and higher-than-expected DPS remuneration. A solid balance sheet with a Solvency ratio above the regulatory requirements makes Generali a potential M&A hunter. Valuation remains reasonable considering the company's strong performance. Our buy rating is then...
Generali reorganises business structure ahead of new strategic plan
Italy's top insurer Generali said on Thursday it was reorganising to focus on its two core businesses and streamline its geographical layout to be ready for the new strategic cycle.
Buy Generali For Its 5.6% Yield
Assicurazioni Generali offers a high-dividend yield and is trading at a discounted valuation compared to peers. Generali's recent financial performance shows strong top-line growth and improved profitability in both life and non-life segments. The company's capital position is strong, allowing...
Generali Completes Acquisition of Conning
HARTFORD, Conn.--(BUSINESS WIRE)--Conning Holdings Limited (Conning and its Affiliates1), a leading global asset manager serving the needs of insurance company and institutional clients, today announced that its acquisition by Generali Investments Holding S.p.A. (GIH), an entity comprising the majority of...
Assicurazioni Generali S.p.A. (ARZGF) Q4 2023 Earnings Call Transcript
Assicurazioni Generali S.p.A. (ARZGF) Q4 2023 Earnings Call Transcript
Italy's Fondazione CRT lifts stake in Generali to 2%, its chairman says
Italy's Fondazione CRT has increased its stake in insurer Generali to around 2% after selling its entire holding in Italian bank Banco BPM last week, its chairman Fabrizio Palenzona said on Tuesday.
Banca Generali boosts full-year dividend as interest income doubles
Italy's Banca Generali will pay a dividend of 2.15 euros ($2.31) per share, up from 1.65 euros per share a year earlier, it said on Thursday.
Generali boosts China presence by acquiring 100% of local JV
Italy's biggest insurer Generali on Wednesday said it would acquire full control of an insurance joint-venture in China after buying the majority stake held by local partner CNPC Capital for around 99 million euros ($108 million).
Generali sees after-tax gain of 300 mln euros from German unit deal
MILAN, Dec 21 (Reuters) - Generali (GASI.MI) said on Thursday it expected to book an after-tax gain of around 300 million euros ($329 million) in the fourth quarter of the year after selling its German specialised pension unit to Fosun-backed...
Generali: A Speculative Buy (Rating Upgrade)
Assicurazioni Generali has solid fundamentals and excess capital, potentially leading to enhanced shareholder remuneration in the short term. Ageas SA/NV has outperformed Generali since the recommendation, up 13.5% vs. less than 4% for Generali. Generali's recent earnings report showed positive...
Source: https://incomestatements.info
Category: Stock Reports